Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update on the efficacy and safety of GZR4 in adults with type 2 diabetes mellitus treated with basal plus prandial insulin, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GZR4

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING